Patient advocates say transparency will help the 340B program realign with its original intent of helping patients. Also, thoughts on supporting small molecules achieving big results. (735 words, 3 ...

Building on the success of the campaign to date, BIO is announcing a new series produced for us by BBC StoryWorks and launching in 2025. In this new iteration, the series will build on the ...

•The FDA is undergoing a strategic reevaluation of its policies under new leadership, prompted by rapid advancements in science and technology. •Now is the time for FDA to pursue a proactive policy ...

Meetings between the Food and Drug Administration (FDA) and industry sponsors are critical to conducting effective and efficient drug development and bringing life-changing, innovative medicines to ...

Don Ware, a Partner at Foley Hoag, has over 40 years’ experience representing leading biopharma manufacturers, research institutions, and universities in patent and inventorship disputes, licensing, ...

BIO President & CEO John F. Crowley announced today that BIO would take several important steps to reaffirm the organization’s position with regards to national security and the role that the industry ...

Under the 340B program, participating manufacturers must offer 340B pricing on their covered outpatient drugs by covered entities, as a condition of having those drugs federally payable under Medicare ...

The Biotechnology Innovation Organization (BIO) is proud to announce that industry leader and military veteran John F. Crowley will be its new President and CEO, effective March 4. He will replace ...

WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical ...

Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry's economic ...

The Biotechnology Innovation Organization (BIO), the California Life Sciences Association (CLSA), and BIOCOM California today filed a challenge against the Department of Health and Human Services’ ...

WASHINGTON - June 5, 2024 – The Biotechnology Innovation Organization (BIO) today announced the winners of the organization’s 2024 Leadership in Agri-Biotechnology Awards — honoring Dr. Annette ...